Japan 2012 Medical Market Led By Antibodies, DPP-4s: IMS
This article was originally published in PharmAsia News
Executive Summary
In a study on domestic pharmaceutical markets in Japan carried out by IMS Japan, the anti-tumor drug market ranked highest for Jan-Dec. 2012 with sales at ¥653.5 billion.